Erratum :Serum paraoxonase activity and oxidative status in subjects with alopecia areata (Cutaneous and Ocular Toxicology (2013) 32:4 (290-293) DOI: 10.3109/15569527.2013.781616));Serum paraoxonase activity and oxidative status in subjects with alopecia areata

Cutaneous and Ocular Toxicology

Volumn 32, Issue 4, 2013, Pages 290-293

  Bilgili, Serap Gunes ^a   Ozkol, Halil ^a   Karadag, Ayse Serap ^b   Uce Ozkol, Hatice ^a   Seker, Ayse ^a   Calka, Omer ^a   Aslan, Mehmet ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Alopecia areata; Oxidative stress index; PON1 activity; Total antioxidant capacity; Total oxidant status

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ALOPECIA AREATA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; OXIDATIVE STRESS;

TOSCANA VIRUS;

ADOLESCENT; ADULT; ALOPECIA AREATA; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; MALE; OXIDATIVE STRESS; YOUNG ADULT;

EID: 84883200389     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2014.944429     Document Type: Erratum

References (30)

1. Halliwell B. Free radicals and antioxidants: Updating a personal view. Nutr Rev 2012;70:257-265
2. Akar A, Arca E, Erbil H, et al. Antioxidant enzymes and lipid peroxidation in the scalp of patients with alopecia areata. J Dermatol Sci 2002;29:85-90
3. Abdel Fattah NSA, Ebrahim AA, El Okda ES. Lipid peroxidation/ antioxidant activity in patients with alopecia areata. J Eur Acad Dermatol Venereol 2011;25:403-408
4. Bodemer C, Peuchmaur M, Fraitaig S, et al. The role of cytotoxic T-cells in chronic alopecia areata. J Invest Dermatol 2000;114: 112-116
5. Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Int J Dermatol 2007;46:121-131
6. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000;42:549-566
7. McDonagh AJ, Messenger AG. Alopecia areata. Clin Dermatol 2001;19:141-147
8. McDonagh AJ, Tazi-Ahnini R. Epidemiology and genetics of alopecia areata. Clin Exp Dermatol 2002;27:405-409
9. Naziroglu M, Kokcam I. Antioxidants and lipid peroxidation status in the blood of patients with alopecia. Cell Biochem Funct 2000;18:169-173
10. Koca R, Armutcu F, Altinyazar CH, Gurel A. Evaluation of lipid peroxidation, oxidant/antioxidant status, and serum nitric oxide levels in alopecia areata. Med Sci Monit 2005;11:296-299
11. Eken A, Dogan P, Karaoglu S, et al. Selenium and glutathione peroxidase in patients with alopecia. Turkderm 1996;30:23-34
12. Gungor S, Akbay G, Ogus E, et al. Changes of lipid peroxidation and antioxidant system in serum and tissues of patients with alopecia areata. Turkiye Clin J Dermatol 2008;18:141-145
13. Blatter MC, James RW, Messmer S, et al. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem 1993;211:871-879
14. Canales A, Sanchez-Muniz FJ. Paraoxanase something more than an enzyme? Med Clin (Barc) 2003;121:537-548
15. Mackness MI, Durrington PN. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis 1995;115:243-253
16. Mackness MI, Abbott C, Arrol S, Durrington PN. The role of high density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J 1993; 294:829-834
17. Aslan M, Kosecik M, Horoz M, et al. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Atherosclerosis 2007;191:397-402
18. Toker A, Kadi M, Yildirim AK, et al. Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct 2009;27:176-180
19. Usta M, Turan E, Aral H, et al. Serum Paraoxonase-1 activities and oxidative status in patients with plaque-type psoriasis with/ without metabolic syndrome. J Clin Lab Anal 2011;25:289-295
20. Karakucuk S, Baskol G, Oner AO, et al. Serum paraoxonase activity is decreased in the active stage of Behçet's disease. Br J Ophthalmol 2004;88:1256-1258
21. Olsen E, Hordinsky M, Price V, et al. Alopecia areata investigational assessment guidelines - Part II. J Am Acad Dermatol 2004; 51:440-447
22. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generationmore stable ABTS radical cation. Clin Biochem 2004;37:277-285
23. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-1111
24. Bolukbas C, Bolukbas FF, Horoz M, et al. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis 2005;5: 95-101
25. Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C. 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992;30:391-395
26. Sezer E, Ozugurlu F, Ozyurt H, et al. Lipid peroxidation and antioxidant status in lichen planus. Clin Exp Dermatol 2007;32: 430-434
27. Taysi S, Demircan B, Akdeniz N, et al. Oxidant/antioxidant status in men with Behçet's disease. Clin Rheumatol 2007;26:418-422
28. Koca R, Armutcu F, Altinyazar HC, Gurel A. Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo. Clin Exp Dermatol 2004;29:406-409
29. Ng CJ, Shih DM, Hama SY, et al. The paraoxonase gene family and atherosclerosis. Free Rad Biol Med 2005;38:153-163
30. Aviram M, Rosenblat M, Billecke S, et al. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Rad Biol Med 1999;26:892-904